242 related articles for article (PubMed ID: 21637006)
21. The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines.
Mok DZL; Chan KR
Viruses; 2020 May; 12(5):. PubMed ID: 32397218
[TBL] [Abstract][Full Text] [Related]
22. Emerging viruses and current strategies for vaccine intervention.
Afrough B; Dowall S; Hewson R
Clin Exp Immunol; 2019 May; 196(2):157-166. PubMed ID: 30993690
[TBL] [Abstract][Full Text] [Related]
23. A systems biology perspective on rational design of peptide vaccine against virus infections.
Chen J; Wang Y; Guo D; Shen B
Curr Top Med Chem; 2012; 12(12):1310-9. PubMed ID: 22690678
[TBL] [Abstract][Full Text] [Related]
24. Genetically modified viruses: vaccines by design.
Stephenson JR
Curr Pharm Biotechnol; 2001 Mar; 2(1):47-76. PubMed ID: 11482348
[TBL] [Abstract][Full Text] [Related]
25. Progress in respiratory virus vaccine development.
Schmidt AC
Semin Respir Crit Care Med; 2011 Aug; 32(4):527-40. PubMed ID: 21858754
[TBL] [Abstract][Full Text] [Related]
26. Noninvasive vaccination against infectious diseases.
Zheng Z; Diaz-Arévalo D; Guan H; Zeng M
Hum Vaccin Immunother; 2018 Jul; 14(7):1717-1733. PubMed ID: 29624470
[TBL] [Abstract][Full Text] [Related]
27. Host receptors: the key to establishing cells with broad viral tropism for vaccine production.
Dai X; Zhang X; Ostrikov K; Abrahamyan L
Crit Rev Microbiol; 2020 Mar; 46(2):147-168. PubMed ID: 32202955
[TBL] [Abstract][Full Text] [Related]
28. Editorial overview: vaccines against challenging viral pathogens and new vaccine technology.
Lu S
Curr Opin Virol; 2014 Jun; 6():viii-ix. PubMed ID: 24831092
[No Abstract] [Full Text] [Related]
29. Animal vaccination and the evolution of viral pathogens.
Schat KA; Baranowski E
Rev Sci Tech; 2007 Aug; 26(2):327-38. PubMed ID: 17892155
[TBL] [Abstract][Full Text] [Related]
30. DNA vaccines: a review.
Lewis PJ; Babiuk LA
Adv Virus Res; 1999; 54():129-88. PubMed ID: 10547676
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic epitopes, heterologous immunity and vaccine design.
Welsh RM; Fujinami RS
Nat Rev Microbiol; 2007 Jul; 5(7):555-63. PubMed ID: 17558423
[TBL] [Abstract][Full Text] [Related]
32. The value of HIV protective epitope research for informed vaccine design against diverse viral pathogens.
Kramer VG; Byrareddy SN
Expert Rev Vaccines; 2014 Aug; 13(8):935-7. PubMed ID: 24964950
[TBL] [Abstract][Full Text] [Related]
33. Viral vectors as vaccine platforms: deployment in sight.
Rollier CS; Reyes-Sandoval A; Cottingham MG; Ewer K; Hill AV
Curr Opin Immunol; 2011 Jun; 23(3):377-82. PubMed ID: 21514130
[TBL] [Abstract][Full Text] [Related]
34. Polymerase Mechanism-Based Method of Viral Attenuation.
Lee CA; August A; Arnold JJ; Cameron CE
Methods Mol Biol; 2016; 1349():83-104. PubMed ID: 26458831
[TBL] [Abstract][Full Text] [Related]
35. Replication-defective viruses as vaccines and vaccine vectors.
Dudek T; Knipe DM
Virology; 2006 Jan; 344(1):230-9. PubMed ID: 16364753
[TBL] [Abstract][Full Text] [Related]
36. Advances in antiviral vaccine development.
Graham BS
Immunol Rev; 2013 Sep; 255(1):230-42. PubMed ID: 23947359
[TBL] [Abstract][Full Text] [Related]
37. Immunity to viruses: learning from successful human vaccines.
Pulendran B; Oh JZ; Nakaya HI; Ravindran R; Kazmin DA
Immunol Rev; 2013 Sep; 255(1):243-55. PubMed ID: 23947360
[TBL] [Abstract][Full Text] [Related]
38. Viral vectors for veterinary vaccines.
Sheppard M
Adv Vet Med; 1999; 41():145-61. PubMed ID: 9890015
[TBL] [Abstract][Full Text] [Related]
39. Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses.
Pandey KK; Sahoo BR; Pattnaik AK
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932228
[TBL] [Abstract][Full Text] [Related]
40. T cell sensitivity and the outcome of viral infection.
Walker LJ; Sewell AK; Klenerman P
Clin Exp Immunol; 2010 Mar; 159(3):245-55. PubMed ID: 19968665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
